BALCX
Price
$36.55
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.37B
PGPCX
Price
$26.52
Change
+$0.01 (+0.04%)
Updated
Jul 18 closing price
Net Assets
2.2B
Interact to see
Advertisement

BALCX vs PGPCX

Header iconBALCX vs PGPCX Comparison
Open Charts BALCX vs PGPCXBanner chart's image
American Funds American Balanced C
Price$36.55
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.37B
George Putnam Balanced C
Price$26.52
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets2.2B
BALCX vs PGPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. PGPCX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and PGPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 252B vs. PGPCX (2.2B). BALCX pays higher dividends than PGPCX: BALCX (1.19) vs PGPCX (1.01). BALCX was incepted earlier than PGPCX: BALCX (24 years) vs PGPCX (26 years). PGPCX (1.68) is less costly to investors than BALCX (1.31). PGPCX is a more actively managed with annual turnover of: 80.00 vs. BALCX (44.00). PGPCX has a lower initial minimum investment than BALCX: PGPCX (0) vs BALCX (250). BALCX annual gain was more profitable for investors over the last year : 6.23 vs. PGPCX (5.63). BALCX return over 5 years is better than : 34.75 vs. PGPCX (26.90).
BALCXPGPCXBALCX / PGPCX
Total Expense Ratio1.311.6878%
Annual Report Gross Expense Ratio1.311.6878%
Fund Existence24 years26 years-
Gain YTD7.7145.217148%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets252B2.2B11,465%
Annual Yield % from dividends1.191.01117%
Returns for 1 year6.235.63111%
Returns for 3 years33.4837.5989%
Returns for 5 years34.7526.90129%
Returns for 10 years55.4762.9288%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTM1.400.07
+5.26%
Castellum
REPX26.551.30
+5.15%
Riley Exploration Permian
WLK83.432.18
+2.68%
Westlake Corp
FHI47.060.57
+1.23%
Federated Hermes
LYRA8.53N/A
N/A
Lyra Therapeutics Inc